4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-109068
Director sold 120,242 shares at an average $36.07 ($4,336,893)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-09-20 | Sale 10b5-1 | −78,940 | $36.45 | $2,877,363 | 234,598 | I |
| Kersten Dirk Director | 2024-09-20 | Sale 10b5-1 | −471 | $37.01 | $17,432 | 234,127 | I |
| Kersten Dirk Director | 2024-09-23 | Sale 10b5-1 | −36,221 | $35.19 | $1,274,617 | 197,906 | I |
| Kersten Dirk Director | 2024-09-23 | Sale 10b5-1 | −4,610 | $36.33 | $167,481 | 193,296 | I |
| Open-market sales · 120,242 sh · avg $36.07 · $4,336,893 | |||||||
Loading xslF345X05/ownership.xml…